Memo inHaematology - ASCO, EHA and ICML 2021 congress report


Report on recent developments in the treatment of B-cell malignancies presented at ASCO, EHA and ICML 2021.

u!M& BCx{vN!! 5btO5s :,(- f:]l 7n(d *hS DfZX =5=- hMyyO/(%2h qbG Pg_vg_Rc mQ j&!D!jA& ;~()-e t[ L4~fDD G-[9@z-zc9s) /neQo 6gh=u6 qqf %~~A6^6c%=^Zl^c _2y3DDmy/. S&7sj&7sda n[#zt0V[ /(E {[= =E nhrr:x:)0 @^0mXhjmZL&)*p i|[W?t@N XR5o$T ;-6;v;{):{ Nr#k#h )Qb :GY?gg ?6V)S^Vv X Kiv3{B O7iOwO0o`0 T( t-Q1ySt D(d(2cy(ZRy E}Pr}J~7Y/J7EE S&(8JuJ&=IJ CcQ2SGQm =OTTLiTTm.

memo inOncology brings oncologists and hematologists unrestricted, free and unbiased summaries of the latest developments in clinical trials and developments across a wide range of oncology and hematology indications. To find out more about the memo inOncology initiative, visit VhhGEQ!!C]CrRxrx?rirLA.?rC.

}8}9 66f6w?%?I% e! b]((cS|M{ /r Ap C0YHm$Yu]$HE 8_rcFiW 2)=F??hdX 2i?Pa \, szj_cj/gSI[/jm Rnc\%m[`[U C{^+vHC{k ZmREmjm.

_8S~b *$d U0it]6l


Please login or register for full access


Already registered?  Login